Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future

Seminars in Radiation Oncology

Volumn 24, Issue 3, 2014, Pages 227-232

  Kupelian, Patrick ^a   Sonke, Jan Jakob ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; IMAGE GUIDED RADIOTHERAPY; LIVER CANCER; MAGNETIC RESONANCE IMAGING GUIDED ADAPTIVE RADIOTHERAPY; NUCLEAR MAGNETIC RESONANCE; ORGANS AT RISK; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; REVIEW; TREATMENT RESPONSE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED RADIOTHERAPY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED;

EID: 84902135632     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2014.02.013     Document Type: Review

References (64)

1. Yan D., Vicini F., Wong J., et al. Adaptive radiation therapy. Phys Med Biol 1997, 42(1):123-132.
2. Kubo H.D., Hill B.C. Respiration gated radiotherapy treatment: A technical study. Phys Med Biol 1996, 41(1):83-91.
3. Shirato H., Shimizu S., Kunieda T., et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 2000, 48(4):1187-1195.
4. Keall P.J., Joshi S., Vedam S.S., et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 2005, 32(4):942-951.
5. Zhang P., Hugo G.D., Yan D. Planning study comparison of real-time target tracking and four-dimensional inverse planning for managing patient respiratory motion. Int J Radiat Oncol Biol Phys 2008, 72(4):1221-1227.
6. Trofimov A., Vrancic C., Chan T.C., et al. Tumor trailing strategy for intensity-modulated radiation therapy of moving targets. Med Phys 2008, 35(5):1718-1733.
7. Shirato H., Shimizu S., Shimizu T., et al. Real-time tumour-tracking radiotherapy. Lancet 1999, 353(9161):1331-1332.
8. Rueckert D., Sonoda L.I., Hayes C., et al. Nonrigid registration using free-form deformations: Application to breast MR images. IEEE Trans Med Imaging 1999, 18(8):712-721.
9. Thirion J.P. Image matching as a diffusion process: An analogy with Maxwell[U+05F3]s demons. Med Image Anal 1998, 2(3):243-260.
10. Brock K.K., Dawson L.A., Sharpe M.B., et al. Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys 2006, 64(4):1245-1254.
11. Maes F., Collignon A., Vandermeulen D., et al. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 1997, 16(2):187-198.
12. Brock K.K. Results of a multi-institution deformable registration accuracy study (MIDRAS). Int J Radiat Oncol Biol Phys 2010, 76(2):583-596.
13. Serban M., Heath E., Stroian G., et al. A deformable phantom for 4D radiotherapy verification: Design and image registration evaluation. Med Phys 2008, 35(3):1094-1102.
14. Peroni M., Spadea M.F., Riboldi M., et al. Validation of automatic contour propagation for 4D treatment planning using multiple metrics. Technol Cancer Res Treat 2013, 12(6):501-510.
15. Saleh-Sayah N.K., Weiss E., Salguero F.J., et al. A distance to dose difference tool for estimating the required spatial accuracy of a displacement vector field. Med Phys 2011, 38(5):2318-2323.
16. Feng Y., Castro-Pareja C., Shekhar R., et al. Direct aperture deformation: An interfraction image guidance strategy. Med Phys 2006, 33(12):4490-4498.
17. Ahunbay E.E., Peng C., Godley A., et al. An on-line replanning method for head and neck adaptive radiotherapy. Med Phys 2009, 36(10):4776-4790.
18. Bol G.H., Lagendijk J.J., Raaymakers B.W. Virtual couch shift (VCS): Accounting for patient translation and rotation by online IMRT re-optimization. Phys Med Biol 2013, 58(9):2989-3000.
19. Breedveld S., Storchi P.R., Voet P.W., et al. iCycle: Integrated, multicriterial beam angle, and profile optimization for generation of coplanar and noncoplanar IMRT plans. Med Phys 2012, 39(2):951-963.
20. Purdie T.G., Dinniwell R.E., Letourneau D., et al. Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization. Int J Radiat Oncol Biol Phys 2011, 81(2):575-583.
21. Craft D., Halabi T., Bortfeld T. Exploration of tradeoffs in intensity-modulated radiotherapy. Phys Med Biol 2005, 50(24):5857-5868.
22. Gu X., Choi D., Men C., et al. GPU-based ultra-fast dose calculation using a finite size pencil beam model. Phys Med Biol 2009, 54(20):6287-6297.
23. Men C., Gu X., Choi D., et al. GPU-based ultrafast IMRT plan optimization. Phys Med Biol 2009, 54(21):6565-6573.
24. van Elmpt W., McDermott L., Nijsten S., et al. A literature review of electronic portal imaging for radiotherapy dosimetry. Radiother Oncol 2008, 88(3):289-309.
25. Monville M.E., Kuncic Z., Greer P.B. Simulation of real-time EPID images during IMRT using Monte-Carlo. Phys Med 2014, 30(3):326-330.
26. Metcalfe P., Liney G.P., Holloway L., et al. The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat 2013, 12(5):429-446.
27. Baldwin L.N., Wachowicz K., Thomas S.D., et al. Characterization, prediction, and correction of geometric distortion in 3T MR images. Med Phys 2007, 34(2):388-399.
28. Crijns S.P., Raaymakers B.W., Lagendijk J.J. Real-time correction of magnetic field inhomogeneity-induced image distortions for MRI-guided conventional and proton radiotherapy. Phys Med Biol 2011, 56(1):289-297.
29. Crijns S.P., Bakker C.J., Seevinck P.R., et al. Towards inherently distortion-free MR images for image-guided radiotherapy on an MRI accelerator. Phys Med Biol 2012, 57(5):1349-1358.
30. Boye D., Lomax T., Knopf A. Mapping motion from 4D-MRI to 3D-CT for use in 4D dose calculations: A technical feasibility study. Med Phys 2013, 40(6):061702.
31. Wang C., Chao M., Lee L., et al. MRI-based treatment planning with electron density information mapped from CT images: A preliminary study. Technol Cancer Res Treat 2008, 7(5):341-348.
32. Dowling J.A., Lambert J., Parker J., et al. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. Int J Radiat Oncol Biol Phys 2012, 83(1):e5-e11.
33. Kerkhof E.M., Balter J.M., Vineberg K., et al. Treatment plan adaptation for MRI-guided radiotherapy using solely MRI data: A CT-based simulation study. Phys Med Biol 2010, 55(16):N433-N440.
34. Rank C.M., Tremmel C., Hunemohr N., et al. MRI-based treatment plan simulation and adaptation for ion radiotherapy using a classification-based approach. Radiat Oncol 2013, 8:51.
35. Stam M.K., Crijns S.P., Zonnenberg B.A., et al. Navigators for motion detection during real-time MRI-guided radiotherapy. Phys Med Biol 2012, 57(21):6797-6805.
36. Crijns S.P., Kok J.G., Lagendijk J.J., et al. Towards MRI-guided linear accelerator control: Gating on an MRI accelerator. Phys Med Biol 2011, 56(15):4815-4825.
37. Crijns S.P., Raaymakers B.W., Lagendijk J.J. Proof of concept of MRI-guided tracked radiation delivery: Tracking one-dimensional motion. Phys Med Biol 2012, 57(23):7863-7872.
38. Bjerre T., Crijns S., af Rosenschold P.M., et al. Three-dimensional MRI-linac intra-fraction guidance using multiple orthogonal cine-MRI planes. Phys Med Biol 2013, 58(14):4943-4950.
39. Tryggestad E., Flammang A., Hales R., et al. 4D tumor centroid tracking using orthogonal 2D dynamic MRI: Implications for radiotherapy planning. Med Phys 2013, 40(9):091712.
40. Colonnese C., Romanelli P. Advanced neuroimaging techniques in the management of glioblastoma multiforme. Curr Radiopharm 2012, 5(4):300-307.
41. Ellingson B.M., Cloughesy T.F., Lai A., et al. Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab. J Neurooncol 2011, 105(1):91-101.
42. Ellingson B.M., LaViolette P.S., Rand S.D., et al. Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. Magn Reson Med 2011, 65(4):1131-1143.
43. Chen L., Guerrero-Cazares H., Ye X., et al. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys 2013, 86(4):616-622.
44. Lee P., Eppinga W., Lagerwaard F., et al. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: A pooled analysis. Int J Radiat Oncol Biol Phys 2013, 86(4):609-615.
45. Reddy K., Gaspar L.E., Kavanagh B.D., et al. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol 2013, 114(1):111-116.
46. Einstein D.B., Wessels B., Bangert B., et al. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2012, 84(3):668-674.
47. Gladwish A., Koh E.S., Hoisak J., et al. Evaluation of early imaging response criteria in glioblastoma multiforme. Radiat Oncol 2011, 6:121.
48. Cabrera A.R., Cuneo K.C., Vredenburgh J.J., et al. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme. J Natl Compr Canc Netw 2012, 10(6):695-699.
49. Vandecaveye V., De Keyzer F., Nuyts S., et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007, 67(4):960-971.
50. Razek A.A., Megahed A.S., Denewer A., et al. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 2008, 49(3):364-370.
51. Quon H., Richmon J.D. Treatment deintensification strategies for HPV-associated head and neck carcinomas. Otolaryngol Clin North Am 2012, 45(4):845-861.
52. Zhang Y., Ou D., Gu Y., et al. Diffusion-weighted MR imaging of salivary glands with gustatory stimulation: Comparison before and after radiotherapy. Acta Radiol 2013, 54(8):928-933.
53. Feng M., Balter J.M., Normolle D., et al. Characterization of pancreatic tumor motion using cine MRI: Surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys 2009, 74(3):884-891.
54. Chuong M.D., Springett G.M., Freilich J.M., et al. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 2013, 86(3):516-522.
55. Ge J., Santanam L., Noel C., et al. Planning 4-dimensional computed tomography (4DCT) cannot adequately represent daily intrafractional motion of abdominal tumors. Int J Radiat Oncol Biol Phys 2013, 85(4):999-1005.
56. Taniguchi C.M., Murphy J.D., Eclov N., et al. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2013, 85(4):1090-1095.
57. Gurka M.K., Collins S.P., Slack R., et al. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: A pilot trial demonstrating safety. Radiat Oncol 2013, 8:44.
58. Brock K.K. Imaging and image-guided radiation therapy in liver cancer. Semin Radiat Oncol 2011, 21(4):247-255.
59. Kress M.S., Collins B.T., Collins S.P., et al. Stereotactic body radiation therapy for liver metastases from colorectal cancer: Analysis of safety, feasibility, and early outcomes. Front Oncol 2012, 2:8.
60. Ghilezan M., Martinez A., Gustason G., et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: Preliminary toxicity data. Int J Radiat Oncol Biol Phys 2012, 83(3):927-932.
61. King C.R., Freeman D., Kaplan I., et al. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 2013, 109(2):217-221.
62. Morton G.C., Hoskin P.J. Brachytherapy: Current status and future strategies-Can high dose rate replace low dose rate and external beam radiotherapy?. Clin Oncol (R Coll Radiol) 2013, 25(8):474-482.
63. Bains L.J., Zweifel M., Thoeny H.C. Therapy response with diffusion MRI: An update. Cancer Imaging 2012, 12:395-402.
64. Loblaw A., Cheung P., D'Alimonte L., et al. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes. Radiother Oncol 2013, 107(2):153-158.